you are here:

Oceanaa Biotek Industries Ltd.

BSE Live

May 12, 16:00
6.42 0.12 (1.90%)
Volume
No Data Available
898
  • Prev. Close

    6.30

  • Open Price

    6.30

  • Bid Price (Qty.)

    6.59 (35)

  • Offer Price (Qty.)

    6.60 (1012)

NSE Live

(%)
Volume
No Data Available
  • Prev. Close

  • Open Price

  • Bid Price (Qty.)

    ()

  • Offer Price (Qty.)

    ()

Oceanaa Biotek Industries is not listed on NSE

ANNOUNCEMENTS ON Oceanaa Biotek

  • Apr 30, 2021 16:59 Source: BSE

    Oceanaa Biotek Industries - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    In accordance with the provisions of Regulations 10(5) for intention for an inter-se transfer amongst immediate relative under Regulation 10(1)(a)(i) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, we have received intimation from the acquirer Mrs. Vimala Joseph for following proposed transfer on 27th April 2021 : Name of the Transferor / Acquirer (Donor) Name of the Transferee / Seller (Donor) No. of Shares proposed to be transferred % of Holding Lithya Joseb Vimala Joseph 32,30,000 23.81% Serrena Joseb Vimala Joseph 20,60,005 15.19% A Joseb Raj Vimala Joseph 7,330 0.054% The acquirer could not complete the acquisition and withdraw the acquisition. In this connection intimation under Regulation 10(5) for the aforementioned withdrawal of acquisition received from the acquirer is enclosed herewith.

  • Apr 27, 2021 16:51 Source: BSE

    Oceanaa Biotek Industries - Announcement under Regulation 30 (LODR)-Acquisition

    Sub: Intimation under Regulation 10(5) for intention for an inter-se transfer amongst immediate relative Regulation 10(1)(a)(i) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 In accordance with the provisions of Regulations 10(5) for intention for an inter-se transfer amongst immediate relative under Regulation 10(1)(a)(i) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, we have received intimation from the acquirer for following proposed transfer : Name of the Transferor / Acquirer (Donor) Name of the Transferee / Seller (Donor) No. of Shares proposed to be transferred % of Holding Lithya Joseb Vimala Joseph 32,30,000 23.81% Serrena Joseb Vimala Joseph 20,60,005 15.19% A Joseb Raj Vimala Joseph 7,330 0.054% All the shares as aforementioned are inter-se transfer amongst promoter by way of gift and without any consideration.

  • Apr 22, 2021 12:26 Source: BSE

    Oceanaa Biotek Industries - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

    Sr. No. Particulars Details
    1Name of CompayOceanaa Biotek Industries Ltd
    2CINL15549TN2005PLC057919
    3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00
    4Highest Credit Rating during the previous FY 0
    4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
    5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE


    We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No



    Name of the Company Secretary: NA
    Designation: NA
    EmailId: obil@oceanaabiotek.com
    Name of the Chief Financial Officer: NA
    Designation: NA
    EmailId: obil@oceanaabiotek.com

    Date: 22/04/2021

    Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

  • Apr 21, 2021 11:54 Source: BSE

    Oceanaa Biotek Industries - Statement Of Investor Complaints For The Quarter Ended March 2021

    No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
    2002
    Name of the Signatory :- XAVIER JEYARAJ
    Designation :- Managing Director / Whole Time Director

  • Apr 21, 2021 11:40 Source: BSE

    Oceanaa Biotek Industries - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2021

  • Apr 17, 2021 11:58 Source: BSE

    Oceanaa Biotek Industries - Compliances - Compliance Certificate For The Year Ended March, 2021

    OBIL/BSE/03/2021-22 17th April, 2021 To, The Corporate Relations Department BSE Limited, PJ Towers, 1st Floor, Dalal Street, Mumbai - 400 001 Scrip Code: 538019 Dear Sir/ Ma'am Subject :- Compliance Certificate under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We are herewith submitting the Compliance Certificate under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended 31st March, 2021 duly signed on behalf of the Company and Share Transfer Agent, BigShare Services Pvt. Ltd. Kindly update the above in your records. Thanking You. For OCEANAA BIOTEK INDUSTRIES LIMITED XAVIER JEYARAJ MANAGING DIRECTOR

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Feb 12, 2021
Remark : Quarterly Results